Clinical Trial Update: Volatile Organic Compounds in Cystic Fibrosis

View source ↗

Summary

A completed clinical trial evaluating volatile organic compounds in cystic fibrosis patients.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cystic Fibrosis

Snippet

Sponsor: Landon Pediatric Foundation | Conditions: Cystic Fibrosis, Pseudomonas Aeruginosa | Status: COMPLETED